08.02.2022 CompuGroup Medical SE & Co. KGaA  DE000A288904

DGAP-News: CompuGroup Medical shows excellent progress in hospital business based on next generation technology and new scale


 

DGAP-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Miscellaneous
CompuGroup Medical shows excellent progress in hospital business based on next generation technology and new scale

08.02.2022 / 10:41
The issuer is solely responsible for the content of this announcement.


- Successful year 2021 with excellent orders from hospitals leading in digitization

- CGM HIS now one of the leading providers of hospital information systems in Europe after successful post-merger integration of largest acquisition in company history

- Enhanced portfolio by adding imaging solutions (VISUS) and data warehouse systems (KMS) through M&A

- Successfully tackling attractive growth market social care with high profile order (Bethel) and new cloud-based offering for social care services under development

- Organic growth profile further strengthened through Hospital Future Act

Koblenz. CompuGroup Medical (CGM), one of the leading e-health providers in the world, is looking back on a successful year 2021 in its Hospital Information Systems segment. Following the successful completing of the post-merger integration of the largest acquisition in CGM's history, the company's hospital business is now one of the leading providers of hospital information systems, laboratory information systems, social care imaging solutions and enterprise resource planning tools in Europe. With a significantly strengthened market position in the German core market, the hospital business is benefitting from new scale, building on an excellent customer base of more than 2,150 clinical and social providers. The company has won several outstanding projects with clinical institutions that are leading in digitization like Universitätsklinik Hamburg-Eppendorf (UKE), one of Europe's leading university clinics. This is testimony to the cutting-edge technological set-up of CGM's innovative product platform. The strong organic growth was driven by numerous digitization initiatives in the company's markets, for example adding connectivity and communication features in Germany and COVID-19 related solutions in the lab business.

In 2021, CGM has enhanced its hospital portfolio with targeted add-on M&A. VISUS Health IT, one of the leading providers for IT-solutions to process and archive radiology images and data was fully integrated into the HIS segment. VISUS is providing more than 1,500 customers, thereof more than 900 clinics and more than 600 medical practices, with products that support the digital journey of CGM's hospital customers. VISUS software solutions facilitate the complex evaluation of medical images on the basis of Artificial Intelligence. In addition, KMS, the leading provider of data warehouse solutions, has strengthened CGM's portfolio since the previous year. With this, now fully integrated function, CGM adds value to more than 350 customers' business models through delivering tools for optimizing the clinical workflow based on process related data.

In the social area, end-to-end process support is a key prerequisite for successful digital transformation. CompuGroup Medical is offering a broad range of products and solutions tailored to post-acute customers' needs. The recent order from the German foundation Bethel, one of the largest diaconal institutions in Europe, confirms CGM's high quality product portfolio. The order includes the cloud enabled CGM SOZIAL HR Management, which is built on G3 technology and provides Bethel with a mobile treatment documentation service and a new web-based tool for resource and deployment planning for more than 20,000 employees. Looking ahead, there is an increasing need for mobile social services in the outpatient care market across Europe. CompuGroup Medical continues to invest in this growth area to launch further G3 based solutions until mid-2022. With this fully cloud-based product, CGM follows the megatrend of connected care for the benefit of the increasing number of people in need of treatment at home.

The need for digitization in the hospital sector has been additionally highlighted by the COVID-pandemic. As a response, the German government has passed the Hospital Future Act, defining a clear support process throughout the whole patient journey. This process starts before the hospital visit. After a visit at a general practitioner, the patient can book an appointment in a hospital. The hospital supports its patients through the digital onboarding process with apps for questionnaires and checklists and provides all the information and education needed. During this process, the patient can access the schedule or transfer-plans to post-acute areas or any following treatments. CompuGroup Medical is offering a broad range of products and solutions to support clinical customers in their digital transformation under the Hospital Future Act. In combination with CGM's CLICKDOC platform, it is possible to offer customized, white labeled patient portals for hospitals, deeply integrated into its workflows. In 2021, there has been intense activity supporting clinical customers assessing their digital progress and applying for the funding of specific projects. This has resulted in a funnel of leads, with the majority of customers still waiting for the funding approval. Until now, CGM has received confirmed orders relating to the Hospital Future Act of more than EUR 20 million, thus delivering on its expectations published last year.

"In 2021, the hospital segment has showed great progress at all future-relevant points," said Hannes Reichl, Managing Director Inpatient & Social Care, "We boosted the organic growth, complemented the portfolio by targeted M&A, and we are fully prepared for one of the greatest regulatory tailwinds we have seen in a long time in this space. The pandemic has pushed the hospital digitization to a new speed level and for these future challenges of all participants in the health care sector we are developing and delivering new products."


About CompuGroup Medical SE & Co. KGaA
CompuGroup Medical is one of the leading e-health companies in the world. With a revenue base of EUR 837 million in 2020, its software products are designed to support all medical and organizational activities in doctors' offices, pharmacies, laboratories and hospitals. Its information services for all parties involved in the healthcare system and its web-based personal health records contribute towards safer and more efficient healthcare. CompuGroup Medical's services are based on a unique customer base of more than 1.6 million users, including doctors, dentists, pharmacists, and other healthcare professionals in inpatient and outpatient facilities. With locations in 18 countries and products in 56 countries worldwide, CompuGroup Medical is the e-health company with one of the highest coverages among healthcare professionals. More than 8,500 highly qualified employees support customers with innovative solutions for the steadily growing demands of the healthcare system.

Contact for media representatives:
Michael Franz
Head of Brand Communication
P +49 261 8000-6100
F +49 261 8000-3100
E-mail: [email protected]

Contact for analysts and investors:
Claudia Thomé
Corporate Vice President Investor Relations
P +49 261 8000-7030
F +49 261 8000-3200
E-mail: [email protected]



08.02.2022 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: CompuGroup Medical SE & Co. KGaA
Maria Trost 21
56070 Koblenz
Germany
Phone: +49 (0)261 8000 7030
Fax: +49 (0)261 8000 3200
E-mail: [email protected]
Internet: www.cgm.com
ISIN: DE000A288904
WKN: A28890
Indices: MDAX, TecDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1277992

 
End of News DGAP News Service

1277992  08.02.2022 

fncls.ssp?fn=show_t_gif&application_id=1277992&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023e
Umsatzerlöse1 582,38 717,02 745,81 837,26 1.025,32 1.129,74 1.187,66
EBITDA1,2 128,44 187,84 178,13 197,48 213,39 216,35 229,76
EBITDA-Marge3 22,05 26,20 23,88 23,59 20,81 19,15
EBIT1,4 90,07 143,23 115,27 121,77 102,68 104,03 113,96
EBIT-Marge5 15,47 19,98 15,46 14,54 10,01 9,21 9,60
Jahresüberschuss1 31,74 96,34 66,15 73,42 69,03 74,12 46,87
Netto-Marge6 5,45 13,44 8,87 8,77 6,73 6,56 3,95
Cashflow1,7 85,82 136,35 110,50 149,93 165,27 145,03 179,53
Ergebnis je Aktie8 0,63 1,92 1,33 1,40 1,30 1,40 0,88
Dividende8 0,35 0,50 0,50 0,50 0,50 0,50 0,35
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2023 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: KPMG

INVESTOR-INFORMATIONEN
©boersengefluester.de
CompuGroup Medical
WKN Kurs in € Einschätzung Börsenwert in Mio. €
A28890 29,220 Halten 1.570,12
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
22,48 35,86 0,63 25,08
KBV KCV KUV EV/EBITDA
2,55 8,75 1,32 9,79
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
0,50 1,00 3,42 22.05.2024
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
08.05.2024 08.08.2024 07.11.2024 28.03.2024
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
-5,99% -20,41% -22,90% -39,88%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu CompuGroup Medical SE & Co. KGaA  ISIN: DE000A288904 können Sie bei EQS abrufen


Software , A28890 , COP , XETR:COP